Adopting NGS for Tumor Profiling: Accessible Sequencing. Flexible Solutions | Illumina Webinar

2016年5月23日

In this webinar, you’ll learn how comprehensive tumor profiling with next-generation sequencing (NGS) can help you avoid costly and time-consuming iterative testing. Discover the efficiencies of comprehensive tumor profiling with NGS. - Decrease precious sample requirements. - Minimize workflow protocols and reduce turn-around time. - Simplify reporting by accessing all relevant genes in one panel. - Reduce costs by accessing multiple genes at once. Explore new sample to data oncology solutions. - Leverage an easy-to-use portfolio of targeted cancer gene panels. - See the power and simplicity of the MiniSeq™ Benchtop Sequencer. - Experience automated, simplified analysis tools. Presenters: Maude Champagne, Commercial Development Manager, Oncology, Illumina, Inc. Claire Ray, Associate Product Manager, Oncology, Illumina, Inc. Subscribe to the Illumina video channel: http://www.youtube.com/subscription_center?add_user=IlluminaInc View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View other Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View cancer genomic videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaiQbVkCco7Kre3KkyElP04h View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

この記事を共有します